Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Int J Anesthesiol Pain Med. 2016 Aug 2;2(1):3. doi: 10.21767/2471-982X.100012

Table 1.

Effect of bupivacaine concentrations on MSC viability. Percentage of viable cells after exposure to medium containing 0.01 mM, 0.1 mM, 0.5 mM and 1 mM of bupivacaine normalized to basal medium control (0 mM) with standard error. Data represents 3-4 independent experiments.

Concentration 0 mM 0.01 mM 0.1 mM 0.5 mM 1 mM
% Viability at 24 hours 100 ± 4% 86 ± 3% 70 ± 3% 64 ± 0% 43 ± 2%
% Viability at 48 hours 100 ± 4% 105 ± 4% 90 ± 2% 62 ± 35 38 ± 4%